Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs
"When you’re selling $1 billion a year or more of a drug, it’s very tempting for a company to just ignore the traffic ticket and keep speeding.”
Another Risk of Death Linked to Atypical Antipsychotics
"The risk was greater for individuals prescribed atypical rather than conventional drugs."
Antipsychotic Drugs and Risk of Venous Thromboembolism: Nested Case-Control Study BMJ
Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young
The prescribed drugs transformed Kyle Warren from a rambunctious healthy child into a drooling, sedated, obese, “shell.”
Making a Killing–Marketing Exercises by Dr. Carl Elliott
The catalyst for Dr. Elliott’s article was the tragic case of Dan Markingson, a 26-year old who committed suicide in May 2004, while enrolled in the CAFE trial, prescribed Seroquel. This case encapsulates the tragic consequences of a broken system which is not designed to detect the hazards for human subjects posed by market-driven research.
Anesthesiologist who Committed Major Fraud Claims Bipolar Defense
"He was one of the most prolific investigators in the area of postoperative pain management. His fraud sets back our knowledge in the field tremendously.” Dr. Steve Shafer, the editor in chief of Anesthesia & Analgesia.
NYT Promotes Alzheimer’s Expansion
New York Times reporter Gina Kolata, broadcasts medical hype on the front page of the paper much the way Judith Miller broadcast hype fed to her by Ahmed Chalabi and the Iraq war lobby.[1]
Columbia Brain Imaging Violations Condemned by Peers
"any slipshod work involving volunteers in clinical trials sends a shudder through the field," said Dr. Gary Small, a professor of psychiatry and biobehavioral sciences at UCLA
Columbia Brain Imaging Research Suspended
“There could be a patient safety issue, for one, and there could be a scientific validity issue. If you’re exposing people to radiation and getting garbage data, then that becomes an ethical problem.”
NIH Needs Sunshine Law Enforcement
The dust-up involving Dr. Charles Nemeroff and Dr. Thomas Insell, director of NIMH shines a light on NIH leaders whose failure to enforce federal disclosure requirements is brushed off with excuses so untenable they have the ring of theater of the absurd.
NIH Reform Compromised By Chief NIMH Psychiatrist
"Dr. Nemeroff has become the poster child for what’s wrong with academic medicine in our country." Dr. Thomas Insell, Director of the NIMH, quietly helped him get a prized position at the University of Miami.
Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks
Despite the fact that children may be at highest risk of antidepressant-induced suicide, GlaxoSmithKline is testing Paxil on 7 to 18 year old Japanese children.
“Unhinged: the Trouble with Psychiatry”
"The resulting frenzy of psychiatric diagnoses has damaged the credibility of everyone in the field."